 Source: Shutterstock.com Lava Therapeutics NASDAQ: LVTX stock is rocketing higher on Monday as investors react to news of an exclusive global license agreement with SeagenNASDAQ: SGEN . This agreement has Seagen agreeing to develop, manufacture and commercialize LAVA-1223. 